Sen-Jam Pharmaceutical

About

Sen-Jam Pharmaceutical is dedicated to improving the treatment of inflammation-based diseases. Founded in 2014, the company focuses on enhancing clinical outcomes for patients with conditions such as viral respiratory infections, arthritis, and opioid withdrawal. Its mission is to extend longevity through innovative anti-inflammatory treatments that target the root causes of autoimmune inflammation. The company utilizes patented proprietary technology that combines two proven molecular agents to create effective anti-inflammatory products. Its product lineup includes SJP-001, which is in Phase 2 clinical trials for alcohol-induced inflammation; SJP-100, an injectable solution for severe inflammation in hospital settings; and SJP-005, a non-opioid solution designed to ease opioid withdrawal symptoms. Sen-Jam Pharmaceutical collaborates with various partners to expand its global reach and promote its innovative pharmaceutical solutions.